Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis

Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutrophil cytoplasmic antibody (ANCA) associated vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuckerman, Roman, Patel, Mayurkumar, Costanzo, Eric J, Dounis, Harry, Haj, Rany Al, Seyedali, Seyedehsara, Asif, Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533989/
https://www.ncbi.nlm.nih.gov/pubmed/29738027
http://dx.doi.org/10.1590/2175-8239-JBN-3858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533989/
https://www.ncbi.nlm.nih.gov/pubmed/29738027
http://dx.doi.org/10.1590/2175-8239-JBN-3858

Ejemplares similares